Employment Agreement


 Exhibit 10.28 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of
July 31, 2006 (the “Effective Date”) between Abraxis BioScience Inc., a Delaware corporation (the “Company”) and Lisa Gopalakrishnan (the “Executive”). 
 RECITAL 
 The Company desires to employ the Executive, and the Executive desires
to be so employed by the Company, on the terms and subject to the conditions set forth in this Agreement. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the premises and the mutual promises set forth in this Agreement, the Company and the Executive hereby agree as
follows: 
  

	 	1.	Definitions. Unless otherwise defined herein, the capitalized terms defined in Exhibit A shall have the meanings therein specified for all purposes of this Agreement.


  

	 	2.	Employment 

  

	 	(a)	Subject to the terms and conditions contained herein, the Company hereby agrees to employ the Executive, and the Executive accepts such employment, on the Effective Date until the
Termination Date. 

  

	 	(b)	During the Executive’s employment under this Agreement, the Executive shall render services to the Company in the position of Executive Vice-President of Finance and subject to
Board of Director approval the Executive shall be appointed Executive Vice-President Chief Financial Officer, effective August 10, 2006. The Executive will be responsible for the overall financial plans and accounting practices of the Company.
The Executive will oversee the treasury, accounting, budget, tax and internal and external audit activities of the organization and its subsidiaries. Furthermore the Executive will oversee the financial and accounting system controls and standards
including but not limited to Company’s compliance with the Sarbanes-Oxley Act of 2002, as amended, and ensure the timely preparation and filing of all financial and statistical reports for management, the Board and any State or Federal agency.
The Executive will report to the Chairman and Chief Executive Officer of the Company. 

  

	 	(c)	In performing her services hereunder, the Executive shall abide by the rules, regulations, and practices as adopted or modified from time to time in the Company’s sole
discretion. 

  

	 	(d)	 The Executive will devote her entire business time, energy, attention and skill to the services of the Company and to the promotion of its interests. So long as




  

 1 








	 	 
the Executive is employed by the Company, the Executive shall not, without the written consent of the Company: 


  

	 	(i)	engage in any other activity for compensation, profit or other pecuniary advantage, whether received during or after the term of this Agreement; 

  

	 	(ii)	render or perform services of a business, professional, or commercial nature other than to or for the Company, either alone or as an employee, consultant, director, officer, or
partner of another business entity (including serving on boards of directors), whether or not for compensation; or 

  

	 	(iii)	plan or otherwise take any preliminary steps, either alone or in concert with others, to establish or engage in any business or activity that would compete with the current or
proposed business of the Company; 

 provided, that it shall not be a violation of this Agreement for the Executive to
(i) serve on civic or charitable boards or committees, (ii) deliver lectures or fulfill speaking engagements, (iii) manage personal investments and (iv) perform such other activities as the Chief Executive Officer may approve, so
long as such activities do not interfere materially with the performance of the Executive’s responsibilities as the Chief Financial Officer of the Company. 
  

	 	(e)	Prior to or concurrently with the execution of this Agreement, the Executive has executed an Executive Proprietary Information, Trade Secret and Confidentiality Agreement (the
“Confidentiality Agreement”). 

  

	 	3.	Location of Employment: The Executive’s principal place of employment shall be at the principal executive office of the Company (currently located in Los Angeles,
California); provided that at the reasonable direction of the Chief Executive Officer the Executive may, from time to time, be required to travel to various domestic and foreign locations for purposes consistent with her duties hereunder.


  

	 	4.	Compensation. 

  

	 	(a)	In exchange for full performance of the Executive’s obligations and duties under this Agreement, the Company shall pay the Executive a salary at the rate of Four Hundred
Thousand ($400,000) per year (“Base Salary”). The Base Salary shall be paid in accordance with the Company’s regularly established payroll practice. The Base Salary will be reviewed from time to time in accordance with the established
procedures of the Company for adjusting salaries for similarly situated employees and may be adjusted in the sole discretion of the Chief Executive Officer. 

  

	 	(b)	 The Base Salary hereof is a gross amount, and the Company shall be required to withhold from such amount deductions with respect to Federal, state and 



  

 2 








	 	 
local taxes, FICA, unemployment compensation taxes and similar taxes, assessments or withholding requirements. 


  

	 	(c)	During the Executive’s employment under this Agreement, the Executive shall also be reimbursed by the Company for reasonable business expenses actually incurred or paid by the
Executive, consistent with the policies established by the Board, in rendering to the Company the services provided for in this Agreement. 

  

	 	(d)	The Executive shall be entitled to vacation and sick leave on terms equivalent to those of other executive officers of the Company. 

  

	 	(e)	The Executive shall be entitled to participate in all benefit plans (including but not limited to any medical, dental, life insurance, retirement and disability plans) which shall
be available from time to time to the executive officers of the Company generally including any stock option, stock purchase or other plan relating to shares of capital stock of the Company or its affiliates. The Executive acknowledges and agrees
that the Company may, in its discretion, terminate at any time or modify from time to time any such benefit plans. 

  

	 	(f)	Commencing in 2007 (for stock option awards determined by the Board with respect to the 2006 fiscal year), the Executive shall be entitled to receive annual grants of stock options
(at the same time such grants are made to the other executive officers of the Company), in such amounts and subject to such terms as may be determined in the sole discretion of the Board or the Company’s Compensation Committee.


  

	 	(g)	The Executive shall be entitled to receive an annual bonus in such amount, and subject to such performance targets and other factors, as may be determined in the sole discretion of
the Board of Directors or Compensation Committee. The target bonus amounts and performance targets for the Executive shall be established at the same time such amounts and targets are established for the other executive officers of the Company, and
any bonuses earned shall be paid at the same time as bonuses for other executive officers. The Executive acknowledges that her target bonus for the 2006 fiscal year will be a minimum of fifty percent (50%) of her Base Salary prorated for the
partial year as determined by the Company pursuant to its standard policy. 

  

	 	(h)	Within thirty (30) days of the Effective Date the Company shall pay the Executive a one time sign on bonus of One Hundred Thousand Dollars ($100,000) in cash, (the “Sign
On Bonus”), in lieu of any other up front payments including reimbursement for relocation costs and expenses. If the Executive voluntarily terminates her employment with the Company pursuant to Section 6(e) on or before one (1) year
from the Effective Date the Executive will repay the Company the Sign On Bonus in cash within thirty (30) days of her Termination Date. 

  

 3 








	 	(i)	Subject to Board of Director approval, the Company will provide the Executive with an option to purchase thirty-five thousand (35,000) shares of the Company common stock, which
option (a) shall have an exercise price equal to the trading price of the Company common stock at the grant date, (b) shall vest in equal installments of 8,750 over a four year period, (c) shall be evidenced by the Company’s
standard form of stock option agreement for its officers and shall otherwise be subject to the terms and conditions of the Company’s stock incentive plan. 

  

	 	(j)	Other than as expressly set forth in this Section 4, the Executive shall not receive any other compensation or benefits except to the extent provided by the Board.


  

	 	5.	Term. The Executive’s employment hereunder shall commence on the Effective Date and shall continue in effect until terminated pursuant to Section 6 below.


  

	 	6.	Termination. The Executive’s employment hereunder may be terminated as follows: 

  

	 	(a)	The employment of the Executive under this Agreement shall terminate on the date of the Executive’s death. 

  

	 	(b)	The employment of the Executive under this Agreement may be terminated by the Company immediately upon giving the Executive notice if the Executive becomes Disabled.


  

	 	(c)	The employment of the Executive under this Agreement may be terminated by the Company immediately upon giving the Executive notice upon the occurrence of Cause.


  

	 	(d)	In addition to the circumstances described in subsection (c) above, the Company may terminate the Executive’s employment at any time (immediately upon giving notice to the
Executive) for any reason or no reason, with or without Cause or prior notice. 

  

	 	(e)	(i) The Executive may voluntarily terminate her employment under this Agreement by giving the Chief Executive Officer written notice of her resignation signed by the Executive or,
if no notice is given, on the date on which the Executive voluntarily terminates her employment relationship with the Company; (ii) Such voluntary termination shall be deemed for purposes hereof to have occurred for “Good Reason” only
if (1) the Executive provides written notice to the Company within twenty (20) days after the Executive becomes aware of the circumstances giving rise to “Good Reason”, (2) the Company fails to correct the circumstances
giving rise to “Good Reason” within thirty (30) days following receipt of such notice and (3) the Executive resigns within fifteen (15) days following such thirty (30) day period. 

  

 4 








	 	7.	Consequences of Termination. 

  

	 	(a)	If the employment of the Executive under this Agreement is terminated pursuant to Section 6(d) (Termination Without Cause); Section 6(e)(ii) (Voluntary Termination for
Good Reason) or a Covered Termination then the Executive shall not be entitled to any compensation or benefits from the Company, under this Agreement or otherwise, except for the following: 

  

	 	(i)	The Company shall pay to the Executive all Accrued Compensation; 

  

	 	(ii)	The Company shall pay the Executive, for the duration of the Severance Period, severance payments at an annual rate (pro rated over the Severance Period) equal to (1) the Base
Amount plus (2) the Bonus Amount, which severance payments will be payable in arrears in monthly installments. Such monthly installments will be delayed to the minimum extent necessary to meet the requirements of Internal Revenue Code
Section 409A, as amplified by any applicable Internal Revenue Service or U.S. Treasury Department guidance. The Company and the Executive shall reasonably cooperate with each other to avoid the imposition of any additional taxes, interest
and/or penalty to the executive under Internal Revenue Code Section 409A; 

  

	 	(iii)	The vesting of the stock options granted to the Executive under subsection 4(i) above shall accelerate so that such options shall have vested to the same extent as would if the
Executive were terminated on the last day of the Severance Period; 

 provided, that the Executive shall not be entitled to
receive any post-termination benefits described in clause (i), (ii) and (iii) of this subsection (a) unless, within twenty-one (21) days following the Termination Date, she executes and delivers to the Company a Release of Claims
in the form attached as Exhibit B hereto. 
  

	 	(b)	The Executive agrees that all property (including, without limitation, all equipment, tangible proprietary information, documents, records, notes, contracts and computer-generated
materials) furnished to or created or prepared by Executive incident to Executive’s employment belongs to the Company and shall be promptly returned to the Company upon termination of the Executive’s employment. 


 

	 	(c)	Upon termination of the Executive’s employment, the Executive shall be deemed to have resigned from all offices and directorships then held with the Company. Following any
termination of employment, the Executive shall reasonably cooperate with the Company (i) in the winding up of pending work on behalf of the Company and the orderly transfer of work to other employees and (ii) in the defense of any action
brought by any third party against the Company that relates to the Executive’s employment by the Company; provided, that in each case the Company shall reimburse the executive for any out-of-pocket fees and expenses incurred by the Executive in
connection with such cooperation. 

  

 5 








	 	8.	Additional Post-Termination Obligations. 

  

	 	(a)	In the event that Executive receives severance payments pursuant to Section 7(a), the Executive agrees that for a period of eighteen months (18) following the Termination
Date, the Executive will not, directly or indirectly, engage in any business activity that is or may reasonably be found to be in competition with the business of the Company and its subsidiaries as such business may exist at any time from the
Effective Date through the Termination Date; provided, that nothing in this Agreement shall be deemed to prohibit Executive from owning not more than one percent (1%) of any class of publicly traded securities of a competitor.


  

	 	(b)	The Executive further agrees that for a period of eighteen months (18) following the Termination Date the Executive will not, directly or indirectly: 


 

	 	(i)	Solicit, raid, entice or induce any employee of the Company to be employed by any competitor of the Company (except to the extent that such employee has first responded to a general
advertisement or general employment search by Executive’s place of employment at the time); 

  

	 	(ii)	Solicit business for any competitor from, or transact such business for any competitor with, any person, firm or corporation which was, at any time during Executive’s
employment hereunder, a customer of the Company; or 

  

	 	(iii)	Assist a competitor in taking such action. 

  

	 	(c)	Executive agrees that she will not disparage, or otherwise communicate to anyone, information which may be harmful to the Company’s business or the business reputation of the
Company, its affiliates or their respective employees, officers, directors, customers, suppliers, successors, and assigns, including without limitation, negative comments about the Company, its management methods, policies and/or practices.
Notwithstanding the foregoing, Executive may respond accurately and fully to any question, inquiry or request made in connection with any governmental inquiry, investigation, review, audit, or proceeding, or as otherwise required by law.


  

	 	(d)	 If the Executive fails to perform her obligations under this Section 8, then the Company may, in addition to any rights and remedies then available to the
Company (under Section 11 hereof or otherwise), cease providing the payments and benefits described in Section 7(a) so long 



  

 6 








	 	 
as such failure, if reasonably capable of being cured, is not cured by the Executive within thirty (30) days following a written notice from the Company
of such failure to perform. 


  

	 	9.	Representations. 

  

	 	(a)	The Executive represents that she has full authority to enter into this Agreement and is not under any contractual restraint which would prohibit the Executive from satisfactorily
performing her duties to the Company under this Agreement. 

  

	 	(b)	The Executive hereby agrees to indemnify and hold harmless the Company, its officers, directors and stockholders from and against any losses, liabilities, damages or costs
(including reasonable attorney’s fees) arising out of a material breach of any of the representations, warranties and covenants of the Executive set forth in this Agreement. 

  

	 	(c)	The Executive acknowledges that she is free to seek advice from independent counsel with respect to this Agreement. The Executive has either obtained such advice or, after carefully
reviewing this Agreement, has decided to forego such advice. The Executive is not relying on any representation or advice from the Company or any of its officers, directors, attorneys or other representatives regarding this Agreement, its content or
effect. 

  

	 	10.	Arbitration. Subject to Section 11 below, the parties acknowledge and agree to the provisions of the Arbitration Agreement attached hereto as Exhibit C and incorporated
by this reference. 

  

	 	11.	Equitable Relief. Notwithstanding Section, 10 above, the Executive acknowledges that the Company is relying for its protection upon the existence and validity of the
provisions of this Agreement, that the services to be rendered by the Executive are of a special, unique and extraordinary character, and that irreparable injury will result to the Company from any violation or continuing violation of the provisions
of Section 8(b) for which damages may not be an adequate remedy. Accordingly, the Executive hereby agrees that in addition to the remedies available to the Company by law or under this Agreement, the Company shall be entitled to obtain such
equitable relief as may be permitted by law in a court of competent jurisdiction including, without limitation, injunctive relief from any violation or continuing violation by the Executive of any term or provision of Section 8(b). If the
Company seeks to enforce its rights under this Section 11, the prevailing party or parties shall be entitled to recover reasonable fees, costs and expenses incurred in connection therewith including, without limitation, the fees, costs and
expenses of attorneys, accountants and experts, whether or not litigation is instituted, and including such fees, costs and expenses of appeals. 

  

 7 








	 	12.	Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the internal substantive laws (and not the laws of conflicts) of the State of
California. 

  

	 	13.	Entire Agreement. This Agreement (including the Exhibits hereto) constitutes the whole agreement of the parties hereto in reference to any employment of the Executive by the
Company and in reference to any of the matters or things herein provided for or hereinabove discussed or mentioned in reference to such employment; all prior agreements, promises, representations and understandings relative thereto being herein
merged. 

  

	 	14.	Assignability. 

  

	 	(a)	This Agreement is personal in nature and the Executive shall not, without the written consent of the Company, assign or transfer this Agreement or any rights or obligations
hereunder. 

  

	 	(b)	Nothing expressed or implied in this Agreement is intended or shall be construed to confer upon or give to any person, other than the parties to this Agreement, any right, remedy or
claim under or by reason of this Agreement or of any term, covenant or condition of this Agreement. 

  

	 	15.	Amendments; Waivers. This Agreement may be amended, modified, superseded, canceled, renewed or extended and the terms or covenants of this Agreement may be waived only by a
written instrument executed by the parties to this Agreement or, in the case of a waiver, by the party waiving compliance. Any such written instrument must be approved by the Company to be effective as against the Company. The failure of any party
at any time or times to require performance of any provision of this Agreement shall in no manner affect the right at a later time to enforce the same. No waiver by any party of the breach of any term or provision contained in this Agreement,
whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such breach, or a waiver of the breach of any other term or covenant contained in this Agreement.


  

	 	16.	Notice. All notices, requests or consents required or permitted under this Agreement shall be made in writing and shall be given to the other parties by personal delivery,
registered or certified mail (with return receipt), overnight air courier (with receipt signature) or facsimile transmission (with “answerback” confirmation of transmission), sent to such party’s addresses or telecopy numbers as are
set forth below such party’s signatures to this Agreement, or such other addresses or telecopy numbers of which the parties have given notice pursuant to this Section 16. Each such notice, request or consent shall be deemed effective upon
the date of actual receipt, receipt signature or confirmation of transmission, as applicable (or if given by registered or certified mail, upon the earlier of (i) actual receipt or (ii) three days after deposit thereof in the United States
mail). 

  

 8 








	17.	Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such
prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.


  

	18.	Survival. The representations and agreements of the parties set forth in Sections 7, 8, 9, 10, 11, and 19 of this Agreement shall survive the expiration or termination of
this Agreement (irrespective of the reason for such expiration or termination). 

  

	19.	IN WITNESS WHEREOF, the parties to this Agreement have executed this Employment Agreement as of the date first above written. 

  

			
	Abraxis BioScience, Inc.
	
	/s/ Patrick Soon-Shiong
	By:	 	Patrick Soon-Shiong, M.D.
	Its:	 	Chief Executive Officer


  

			
	Address for Notices:	 	2730 Wilshire Blvd., Suite 500
		 	Santa Monica, California 90403


  

	
	
	/s/ Lisa Gopalakrishnan
	Lisa Gopalakrishnan
	
	Address for Notices:


  

 9 







 EXHIBIT A 
 DEFINITIONS 
 “Accrued Compensation” shall mean (i) all base salary and vacation pay accrued
through the Termination Date and (ii) reimbursement for reasonable and necessary expenses incurred by the Executive on behalf of the Company during the period ending on the Termination Date. 
 “Base Amount” shall mean the amount of Executive’s annual base salary at the rate in effect on the Termination Date. 
 “Board” means the Board of Directors of the Company. 
 “Severance Bonus Amount” shall mean (i) if the Termination Date occurs after the payment to the Executive of the annual incentive payment under the Company’s cash bonus incentive plan with respect to 2007, an
amount equal to the average of the last two annual incentive payments paid or payable to the Executive prior to the Termination Date, pro rated over the number of days of employment in the calendar year in which the Termination Date occurs
(ii) if the Termination Date occurs after the payment to the Executive of the annual incentive payment under the Company’s cash bonus incentive plan with respect to 2006 (but prior to the payment with respect to 2007), an amount equal to
such payment, pro rated over the number of days of employment in the calendar year in which the Termination Date occurs and (iii) if the Termination Date occurs prior to the payment to the Executive of the annual incentive payment under the
Company’s cash bonus incentive plan with respect to 2006, an amount equal to [50% of her Base Salary for 2006], pro rated over the number of days of employment in the calendar year in which the Termination Date occurs 
 “Cause” shall mean any of the following (i) Executive commits a material breach of this Agreement, the Confidentiality Agreement, or any policy of
the Company; which breach is not cured to the satisfaction of the Board within twenty days after written notice to Executive from the Company; (ii) the Executive fails (other than a failure resulting from a Disability) to substantially perform
her duties hereunder, or to implement or follow a lawful policy or directive of the Company, and such failure continues for a period of twenty days after written notice to Executive from the Company; (iii) the Executive is indicted for a crime
involving dishonesty, breach of trust, physical harm to any person or serious moral turpitude, (iv) the Executive engages in dishonesty, gross negligence or willful misconduct in the performance of her duties, as reasonably determined by the
Board, (v) the Executive engages in conduct which is materially injurious to the Company (monetarily or otherwise) or which constitutes a material violation of federal or state law relating to the Company or its business. 
 “Common Stock” shall mean the Company’s Common Stock 
 “Covered Termination” means a termination of the Executive’s employment by the Company without Cause within twelve months following the date on which (i) the Company engages in a transaction (including a merger,
consolidation, reorganization or recapitalization) pursuant to which the holders of the voting capital stock of the Company immediately prior to such transaction cease to beneficially own more than fifty percent (50%) of voting capital stock of
the Company or its successor (or, if there is a parent of the Company following such transaction, of 

  

 1 







 
the ultimate parent) immediately following such transaction or (ii) the Company sells all or substantially all of its assets to a third party. For
purposes of applying this definition a termination of the Executive’s employment will not be deemed to have occurred if, in connection with a sale of all or substantially all of the assets of the Company, the Executive is offered employment
(whether or not you accept such offer) with the purchaser of any of the assets of the Company. 
 “Disability” means (i) the Executive
becomes eligible for the Company’s long term disability benefits or (ii) in opinion of the Board, Executive has been unable to carry out the responsibilities and functions of the position held by Executive by reason of any physical or
mental impairment for more than ninety consecutive days or more than one hundred and twenty days in any twelve-month period. 
 “Good
Reason” means, without the Executive’s express written consent, the occurrence of any of the following circumstances: (i) there is a change in the Executive’s status or responsibilities which represents a material and adverse
change from the Executive’s overall status or responsibilities, taken as a whole; or (ii) the Executive is required to be based at any place outside a fifty (50) mile radius from the Executive’s then-current principal office
without her written consent, except for travel that is reasonably necessary in connection with the Company’s business; (iii) a reduction in your base salary or benefits (unless, in the case of a reduction in benefits only, such reduction
in benefits applies to all officers of the Company); or (iv) any failure by the successor to the Company to assume and agree to perform the company’s obligations hereunder. 
 “Severance Period” shall mean the period commencing on the Termination Date and ending on the eighteenth month anniversary of such Termination Date. 
 “Termination Date” means the date on which the Executive’s employment is terminated pursuant to Section 6 hereof. 
  

 2 







 EXHIBIT B 
 RELEASE 
 In consideration for the payments described in Section 7 of the Agreement, the
Executive hereby releases and discharges Abraxis BioScience, Inc., and any subsidiaries or affiliates thereof (collectively the “Company”), and their respective directors, officers, employees, benefit plans and administrators, successors
and assigns from any and all claims, obligations, and liabilities, whether known or unknown, at law or in equity, arising out of the Executive’s employment with the Company and the termination thereof. This Release is to be broadly construed so
as to resolve all pending or potential disputes including, but without limiting the generality of the foregoing, any and all claims under the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act of 1990, Title
VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Employee Retirement Income Security Act of 1974, the Equal Pay Act, the Family and Medical Leave Act, the discrimination and wage payment laws of the State of California,
and any other statute, regulation, or ordinance, and any and all claims based upon alleged wrongful or retaliatory discharge, negligence, intentional infliction of emotional distress, defamation, invasion of privacy, other torts, harassment,
employment discrimination or breach of contract (express or implied). Notwithstanding the foregoing, Executive does not waive any rights Executive may have to enforce the terms of the Transition Agreement, if any, to benefits available after
termination under any Company-sponsored employee benefit plan, to insurance protection and/or indemnification for actions taken by the Executive while an employee, officer and/or director of the Company or to make any claims for workers’
compensation. 
 Executive acknowledges and agrees that: (a) Executive has read and understands this Release in its entirety;
(b) Executive has been advised in writing to consult with an attorney concerning this Release before signing it. This subparagraph constitutes such written advice; (c) Executive has twenty-one (21) calendar days after receipt of this
Release to consider its terms before signing it; (d) nothing contained in this Release waives any claim that may arise after the date of its execution; and (e) Executive executes this Release knowingly and voluntarily, without duress or
reservation of any kind, and after having given the matter full and careful consideration. 
 Executive has the right to revoke this Release
in full within seven (7) calendar days of executing it. Any revocation must be personally delivered to the Chief Executive Officer of the Company or his designee, or mailed to AbraxisBioScience, Inc., 2730 Wilshire Blvd., Suite 500, Santa
Monica, California 90403 and postmarked within seven (7) calendar days of the date of execution of this Release. None of the terms and provisions of this Release shall become effective or be enforceable until such revocation period has expired.

  

 3 







 EXHIBIT C 
 ARBITRATION AGREEMENT 
  

	1.	In addition to the Employment Agreement of which this Arbitration Agreement is made an Exhibit, Company and Executive hereby agree that, to the fullest extent permitted by law, any
and all controversies or claims between them (or between Executive and any present or former officer, director, agent, or employee of the Company or any parent, subsidiary, or other entity affiliated with the Company) relating in any manner to the
employment or the termination of employment of Executive shall be resolved by final and binding arbitration. Except as specifically provided herein, any arbitration proceeding shall be conducted in accordance with the National Rules for the
Resolution of Employment Disputes of the American Arbitration Association (“the AAA Rules”) and judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. 

  

	2.	It is the express agreement of the parties that the provisions of this Section, including the rules of the AAA, shall govern the arbitration of any disputes arising pursuant to this
Agreement. In the event of any conflict between the law of the State of California, the law of the arbitral location, and the U.S. Arbitration Act (Title 9, U.S. Code), with respect to any arbitration conducted pursuant to this Agreement, to the
extent permissible, it is the express intent of the parties that the law of California, shall prevail. Either party (the “Initiating Party”) may commence an arbitration by submitting a Demand for Arbitration under the AAA Rules and by
notice to the other Party (the “Respondent”) in accordance with Section 16. Such notice shall set forth in reasonable detail the basic operative facts upon which the Initiating Party seeks relief and specific reference to the clauses
of this Agreement, the amount claimed, if any, and any non-monetary relief sought against the Respondent. After the initial list of issues to be resolved has been submitted, the arbitrators shall permit either party to propose additional issues for
resolution in the pending proceedings. 

  

	3.	The place of arbitration shall be Los Angeles, California, or any other place selected by mutual agreement. 

  

	4.	A neutral and impartial arbitrator shall be chosen by mutual agreement of the Parties; however, if the Parties are unable to agree upon an arbitrator within a reasonable period of
time, then a neutral and impartial arbitrator shall be appointed in accordance with the arbitrator nomination and selection procedure set forth in the AAA Rules. An award rendered in connection with arbitration pursuant to this Arbitration
Agreement) shall be final and binding upon the parties, and any judgment upon such an award may be entered and enforced in any court of competent jurisdiction. 

  

	5.	The parties agree that the award of the arbitral tribunal will be the sole and exclusive remedy between them regarding any and all claims between them with respect to the subject
matter of the arbitrated dispute. The parties hereby waive all jurisdictional defenses in connection with any arbitration hereunder or the enforcement of any order or award rendered pursuant thereto (assuming that the terms and conditions of this
arbitration clause have been complied with). 

  

 4 








	6.	With respect to any award issued by the arbitrators pursuant to this Agreement, the parties expressly agree (i) that such order shall be conclusive proof of the validity of the
determinations) of the arbitrators underlying such order; and (ii) any federal court sitting in Los Angeles, California, or any other court having jurisdiction, may enter judgment upon and enforce such order, whether pursuant to the U.S.
Arbitration Act, or otherwise. 

  

	7.	The arbitrators shall issue a written explanation of the reasons for the award and a full statement of the facts as found and the rules of law applied in reaching their decision to
both parties. Any provisional remedy which would be available to a court of law shall be available from the arbitrators pending arbitration of the dispute. Either party may make an application to the arbitrators seeking injunctive or other interim
relief, and the arbitrators may take whatever interim measures they deem necessary in respect of the subject matter of the dispute, including measures to maintain the status quo until such time as the arbitration award is rendered or the controversy
is otherwise resolved. The arbitrator shall have the authority to award any remedy or relief that a court of the State of California could order or grant, including, without limitation, specific performance of any obligation created under this
Agreement, the issuance of an injunction, or the imposition of sanctions for abuse or frustration of the arbitration process, but specifically excluding punitive damages (the parties specifically agree that punitive damages shall not be available in
the event of any dispute). 

  

	8.	Each party shall pay its own costs and attorney’s fees, unless a party prevails on a statutory claim, and the statute provides that the prevailing party is entitled to a
payment of its attorney’s fees. In that case, the arbitrator may award reasonable attorney’s fees and costs to the prevailing party as provided by law. The costs and fees of the arbitrator shall be paid by Company.


  

	9.	Nothing in this Arbitration Agreement prohibits either party from seeking injunctive or provisional relief from a court of competent jurisdiction to prevent irreparable harm,
pursuant to Section 1281.8 of the California Code of Civil Procedure. 

  

	10.	THE PARTIES ALSO UNDERSTAND AND AGREE THAT THIS AGREEMENT CONSTITUTES A WAIVER OF THEIR RIGHT TO A TRIAL BY JURY OF ANY CLAIMS OR CONTROVERSIES COVERED BY THIS AGREEMENT. THE
PARTIES AGREE THAT NONE OF THOSE CLAIMS OR CONTROVERSIES SHALL BE RESOLVED BY A JURY TRIAL. 

  

	11.	THE PARTIES FURTHER ACKNOWLEDGE THAT THEY HAVE BEEN GIVEN THE OPPORTUNITY TO DISCUSS THIS AGREEMENT WITH THEIR LEGAL COUNSEL AND HAVE AVAILED THEMSELVES OF THAT OPPORTUNITY TO THE
EXTENT THEY WISH TO DO SO. 

  

	
	Abraxis BioScience, Inc.
	
	   
	 By: Patrick Soon-Shiong, M.D.
 Its Chairman



  

 5 








			
	Address for Notices:	 	2730 Wilshire Blvd., Suite 500
		 	Santa Monica, California 90403


  

	
	
	   
	Lisa Gopalakrishnan
	
	Address for Notices:


  

 6